gantenerumab Archives -

Roche’s Genentech division has reported disappointing top-line results from its highly-anticipated phase 3 trial of gantenerumab in early

Alzheimer’s treatment hopes take another dive as Roche drug fails trial

https://pharmaphorum.com/news/alzheimers-treatment-hopes-take-another-dive-as-roche-drug-fails-trial/

The litany of failed trials of amyloid-targeting drugs for Alzheimer’s disease has added another verse, as Roche concedes

Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial

https://pharmaphorum.com/news/another-amyloid-miss-in-alzheimers-as-roches-crenezumab-fails-trial/

With prospects of an early, accelerated approval for Roche’s Alzheimer’s disease candidate gantenerumab looking diminished, the drugmaker has

Roche starts new four-year trial of Alzheimer’s drug gantenerumab

https://pharmaphorum.com/news/roche-starts-new-four-year-trial-of-alzheimers-drug-gantenerumab/

Phase 3 results with Roche’s amyloid-targeting Alzheimer’s drug gantenerumab may not be due until the second half of

Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout

https://pharmaphorum.com/news/roche-talking-to-fda-as-alzheimers-drug-moves-towards-2022-readout/

gantenerumab